«Kallmann Syndrome

Below is an extended Kallmann Syndrome patents listing. Click here to return to the Kallmann Syndrome main in depth entry.

Patents :
US Patent No.	Title
5556786	Anhidrotic ectodermal dysplasia gene and method of detecting same
6251601	Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays
6335170	Gene expression in bladder tumors
6465627	DAX-1 protein, methods for production and use thereof
6479055	Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
6518013	Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission
6548475	Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury
6557394	Smell test device
6689580	Growth factor
6693077	Keratinocyte growth factor-2
6770743	Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury
6235713	Vascular endothelial growth factor-D (VEGF-D) polypeptides
6228983	Human respiratory syncytial virus peptides with antifusogenic and antiviral activities
5700926	Molecular cloning of the anhidrotic ectodermal dysplasia gene
5763166	Gene associated with X linked Kallmann syndrome and diagnostic applications therefrom
6013263	Measles virus peptides with antifusogenic and antiviral activities
6017536	Simian immunodeficiency virus peptides with antifusogenic and antiviral activities
6054265	Screening assays for compounds that inhibit membrane fusion-associated events
6060065	Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission
6068973	Methods for inhibition of membrane fusion-associated events, including influenza virus
6093699	Method for gene therapy involving suppression of an immune response
6093794	Isolated peptides derived from the Epstein-Barr virus containing fusion inhibitory domains
6121231	Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury
6824783	Methods for inhibition of membrane fusion-associated events, including HIV transmission
6833244	Oligonucleotides for detecting male infertility
7189507	Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
7232667	Keratinocyte growth factor-2 polynucleotides
7238667	Albumin fusion proteins
7273614	Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
7291461	Methods for identifying small molecules that modulate premature translation termination and nonsense mRNA decay
7335470	Compilations of nucleic acids and arrays and methods of using them
7341989	Use of LH in controlled ovarian hyperstimulation
7368531	Human secreted proteins
7402558	Method for aiding implantation or decreasing miscarriage rate
7410639	Vascular endothelial growth factor D(VEGF-D) antibodies and methods of use
7153650	Marker system for preparing and characterizing high-quality human embryonic stem cells
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
6846626	Method for amplifying sequences from unknown DNA
6936417	Gene expression in bladder tumors
6951717	Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
7014997	Chromosome structural abnormality localization with single copy probes
7067162	Use of odorants to alter blood flow to the vagina
7087430	Human VNO cDNA libraries
7094543	Methods for detecting rare polymorphic variants in genomic DNA sequences
7108872	Use of odorants to alter blood flow to the vagina, and article of manufacture thereof
7122190	Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids
7122654	Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
7411051	Antibodies to HDPPA04 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.